Renato Rosseto1, Joseph Hajdu. 1. Department of Chemistry and Biochemistry, California State University, 18111 Nordhoff Street, Northridge, CA 91330-8262, USA.
Abstract
A series of new phosphatidylcholine analogues with structurally modified sn-2-substituents have been prepared. The synthetic compounds include oligo(ethylene glycol) derivatives with chain-terminal pharmacophores that upon catalytic hydrolysis by phospholipase A(2) yielded a series of oligo(ethylene glycol)-conjugates of the respective drugs. The approach here outlined may open a new way to employ OEG derivatives of phospholipids for therapeutic applications as secretory PLA(2)-targeted precursors of prodrugs.
A series of new phosphatidylcholine analogues with structurally modified n class="Chemical">sn-2-substituents have been prepared. The synthetic compounds include oligo(ethylene glycol) derivatives with chain-terminal pharmacophores that upon catalytic hydrolysis by phospholipase A(2) yielded a series of oligo(ethylene glycol)-conjugates of the respective drugs. The approach here outlined may open a new way to employ OEG derivatives of phospholipids for therapeutic applications as secretory PLA(2)-targeted precursors of prodrugs.
Authors: Meredith A Bostrom; Boris B Boyanovsky; Craig T Jordan; Marilyn P Wadsworth; Douglas J Taatjes; Frederick C de Beer; Nancy R Webb Journal: Arterioscler Thromb Vasc Biol Date: 2007-01-04 Impact factor: 8.311
Authors: Krishnan Malolanarasimhan; Noemi Kedei; Dina M Sigano; James A Kelley; Christopher C Lai; Nancy E Lewin; Robert J Surawski; Vladimir A Pavlyukovets; Susan H Garfield; Stephen Wincovitch; Peter M Blumberg; Victor E Marquez Journal: J Med Chem Date: 2007-02-07 Impact factor: 7.446
Authors: Andrew S Felts; Chuan Ji; Jennifer B Stafford; Brenda C Crews; Philip J Kingsley; Carol A Rouzer; Mary Kay Washington; Kotha Subbaramaiah; Brianna S Siegel; Shiu M Young; Andrew J Dannenberg; Lawrence J Marnett Journal: ACS Chem Biol Date: 2007-06-29 Impact factor: 5.100